Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Nanoscience and Nanotechnology|March 14, 2012
Program and read scaling trade-offs in phase change memoriesStefania Braga, Alessandro Cabrini, Guido TorelliVaccine|August 18, 2016
The 2015 global production capacity of seasonal and pandemic influenza vaccineKenneth A McLean, Shoshanna Goldin, Claudia Nannei, et al.Vaccine|June 21, 2011
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transferMartin Friede, Laszlo Palkonyay, Claudia Alfonso, et al.Vaccine|June 6, 2018
Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availabilityJan Hendriks, Raymond C W Hutubessy, Gary Grohmann, et al.Vaccine|December 20, 2020
Global production capacity of seasonal and pandemic influenza vaccines in 2019Erin Sparrow, James G Wood, Christopher Chadwick, et al.Vaccine|September 21, 2016
Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a surveyClaudia Nannei, Shoshanna Goldin, Guido Torelli, et al.Biomed Research International|September 25, 2018
Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in FerretsIrina Kiseleva, Elena Krutikova, Ekaterina Stepanova, et al.Plos One|December 4, 2018
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret modelLarisa Rudenko, Irina Kiseleva, Elena Krutikova, et al.Vaccines|November 4, 2018
Two Live Attenuated Vaccines against Recent Low⁻and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in FerretsLarisa Rudenko, Irina Kiseleva, Elena Krutikova, et al.Human Vaccines & Immunotherapeutics|December 15, 2017
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adultsGoran Stevanovic, Lidija Lavadinovic, Svetlana Filipovic Vignjevic, et al.Pageof 2